✦ LIBER ✦

EGFR inhibition in the treatment of non-small cell lung cancer

✍ Scribed by David E. Gerber

Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 154 KB
Volume: 69
Category: Article
ISSN: 0272-4391
DOI: 10.1002/ddr.20268

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Absence of EGFR mutation in the kinase d

Absence of EGFR mutation in the kinase domain in common human cancers besides non-small cell lung cancer

✍ Jong Woo Lee; Young Hwa Soung; Su Young Kim; Won Sang Park; Suk Woo Nam; Jung Yo 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 61 KB 👁 1 views

EGFR mutations in non-small-cell lung ca

EGFR mutations in non-small-cell lung cancer among smokers and non-smokers: A meta-analysis

✍ Jing-Hua Ren; Wen-Shan He; Guo-Li Yan; Min Jin; Kun-Yu Yang; Gang Wu 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 309 KB 👁 1 views

## Abstract Mounting evidence has suggested somatic mutations in the __EGFR__ gene are associated with better responsiveness to __EGFR__ tyrosine kinase inhibitors (TKIs) in patients with non‐small‐cell lung cancer (NSCLC). Some, but not all, studies have reported that the mutations were more frequ

Etoposide in the management of non-small

Etoposide in the management of non-small cell lung cancer

✍ John C. Ruckdeschel 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 387 KB 👁 2 views

Treatment of small-cell lung cancer in e

Treatment of small-cell lung cancer in elderly patients

✍ Athanasios G. Pallis; Frances A. Shepherd; Denis Lacombe; Cesare Gridelli 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB 👁 1 views

HMGA2 overexpression in non-small cell l

HMGA2 overexpression in non-small cell lung cancer

✍ Britta Meyer; Siegfried Loeschke; Anke Schultze; Thomas Weigel; Martin Sandkamp; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 318 KB

## Abstract Lung cancer is still the leading cause of death from cancer worldwide primarily because of the fact that most lung cancers are diagnosed at advanced stages. Overexpression of the high mobility group protein HMGA2 has been observed in a variety of malignant tumors and often correlates wi

Tumor angiogenesis of non–small cell lun

Tumor angiogenesis of non–small cell lung cancer

✍ Noriharu Shijubo; Hiroshi Kojima; Manabu Nagata; Takashi Ohchi; Akihiro Suzuki; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB

## Abstract Lung cancer is one of the commonest causes of cancer death in developed countries. Recent evidence suggests that angoigenesis is related to poor prognosis in many solid tumors including non–small cell lung cancer (NSCLC). Angiogenesis is regulated by a complex interaction among growth f